[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6180 followers
Created: 2025-07-26 07:12:26 UTC

📈 Jagsonpal Pharma Q1 FY2025: Revenue & Profit Surge | Dividend & Stock Options Announced | MCap XXXXXXXX Cr

- Revenue from operations: ₹756.12M in Q1 FY2025 (vs ₹614.39M in Q1 FY2024)
- Total income: ₹784.37M (up from ₹628.83M YoY)
- Profit before tax: ₹144.31M (vs ₹71.10M YoY)
- Net profit: ₹108.52M with EPS of ₹1.60
- XXXXXX stock options granted to employees
- Final dividend recommended: ₹2.5 per share (face value ₹2)
- CFO transition: Sachin Jain stepped down on July 8, 2025

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of X pages)

![](https://pbs.twimg.com/media/GwxBc4PakAAeuDU.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949004870649872504/c:line.svg)

**Related Topics**
[tax bracket](/topic/tax-bracket)
[mcap](/topic/mcap)
[surge](/topic/surge)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1949004870649872504)